As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

emmm201302654.reviewer_comments.pdf281KReview Process File

Figure S1. Netrin-1 receptors gene expression following cytotoxic drugs treatment.

Figure S2. Validation of netrin-1/receptors interference.

Figure S3. Doxorubicin triggers p53 activation.

Figure S4. Wild-type p53 is required for netrin-1 upregulation.

Table S1. Cell sensitivity to cytotoxic drugs.

emmm201302654-sm-0003-SuppFig-S1.pdf121KSupporting Figures

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.